Short-term effects of atorvastatin on haemorheologic parameters, platelet aggregation and endothelium dysfunction in patients with hypercholesterolaemia [1]

European Heart Journal

Volumn 25, Issue 1, 2004, Pages 96-

  Horvath, Beata ^a   Marton, Zsolt ^a   Alexy, Tamas ^a   Kesmarky, Gabor ^a   Toth, Kalman ^a   Szapary, Laszlo ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; FIBRINOGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; VON WILLEBRAND FACTOR;

ADULT; BLOOD FLOW; BLOOD VISCOSITY; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; DISEASE MARKER; DRUG EFFECT; ERYTHROCYTE AGGREGATION; ERYTHROCYTE DEFORMABILITY; ERYTHROCYTE FILTERABILITY; FIBRINOGEN BLOOD LEVEL; HUMAN; HYPERCHOLESTEROLEMIA; LETTER; LEUKOCYTE; PLASMA VISCOSITY; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL; VASCULAR ENDOTHELIUM;

EID: 0347358079     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ehj.2003.05.002     Document Type: Letter

References (3)

1. Riesen WF, Engler H, Risch M et al. Short-term effects of atorvastatin on C-reactive protein. Eur Heart J 2002;23:794-9.
2. Yarnell JW, Baker IA, Sweetnam PM et al. Fibrinogen, viscosity, and white blood cell count are major risk factors for ischaemic heart disease. The Caerphilly and Speedwell collaborative heart disease studies. Circulation 1991;83:836-44.
3. Szapary L, Horvath B, Marton ZS et al. Short term effect of low dose atorvastatin on hemorheological parameters, platelet aggregation and endothelial function in cerebrovascular patients with dyslipidemia. CNS drugs, in press.